Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
作者： Richard N Fedorak , Alfred Gangl , Charles O Elson , Paul Rutgeerts , Stefan Schreiber
关键词: Adverse effect 、 Surgery 、 Rheumatoid arthritis 、 Internal medicine 、 Gastroenterology 、 Corticosteroid 、 Inflammatory bowel disease 、 Medicine 、 Crohn's disease 、 Placebo 、 Asymptomatic 、 Anemia
摘要: … human IL-10 (rhuIL-10) for mild to moderately active Crohn's disease. Methods: We conducted a … daily for 28 days to patients with mild to moderately active Crohn's disease is safe, well-…
gastrojournal.org
ulb.ac.be
core.ac.uk
kuleuven.be
elsevier.com
sci-hub.se 参考文章(21)
E.Jan Irvine, Brian Feagan, James Rochon, André Archambault, Richard N Fedorak, Aubrey Groll, Douglas Kinnear, Fredric Saibil, John W.D McDonald, Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease Gastroenterology. ,vol. 106, pp. 287- 296 ,(1994) , 10.1016/0016-5085(94)90585-1
William E. Pullman, Susan Elsbury, Masanobu Kobayashi, Andrew J. Hapel, William F. Doe, Enhanced Mucosal Cytokine Production in Inflammatory Bowel Disease Gastroenterology. ,vol. 102, pp. 529- 537 ,(1992) , 10.1016/0016-5085(92)90100-D
Gordon Guyatt, Alba Mitchell, E. Jan Irvine, Joel Singer, Nancy Williams, Robert Goodacre, Cathy Tompkins, A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease Gastroenterology. ,vol. 96, pp. 804- 810 ,(1989) , 10.1016/S0016-5085(89)80080-0
R M Bukowski, G T Budd, J A Gibbons, R J Bauer, A Childs, J Antal, J Finke, L Tuason, V Lorenzi, D McLain, Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects. Journal of Clinical Oncology. ,vol. 12, pp. 97- 106 ,(1994) , 10.1200/JCO.1994.12.1.97
Fiona Powrie, T cells in inflammatory bowel disease: protective and pathogenic roles Immunity. ,vol. 3, pp. 171- 174 ,(1995) , 10.1016/1074-7613(95)90086-1
Fiona Powrie, Michael W. Leach, Smita Mauze, Satish Menon, Linda Barcomb Caddle, Robert L. Coffman, Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells Immunity. ,vol. 1, pp. 553- 562 ,(1994) , 10.1016/1074-7613(94)90045-0
SJ van Deventer, CO Elson, RN Fedorak, Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology. ,vol. 113, pp. 383- 389 ,(1997) , 10.1053/GAST.1997.V113.PM9247454
Edward Keystone, Janice Wherry, Paul Grint, IL-10 AS A THERAPEUTIC STRATEGY IN THE TREATMENT OF RHEUMATOID ARTHRITIS Rheumatic Diseases Clinics of North America. ,vol. 24, pp. 629- 639 ,(1998) , 10.1016/S0889-857X(05)70030-2
Ralf Kühn, Jürgen Löhler, Donna Rennick, Klaus Rajewsky, Werner Müller, Interleukin-10-deficient mice develop chronic enterocolitis Cell. ,vol. 75, pp. 263- 274 ,(1993) , 10.1016/0092-8674(93)80068-P
Charles O. Elson, The basis of current and future therapy for inflammatory bowel disease The American Journal of Medicine. ,vol. 100, pp. 656- 662 ,(1996) , 10.1016/S0002-9343(96)00049-6